Annual CFI
-$42.76 M
-$65.85 M-285.23%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual cash flow from investing activities is -$42.76 million, with the most recent change of -$65.85 million (-285.23%) on December 31, 2023.
- During the last 3 years, FUSN annual CFI has risen by +$167.69 million (+79.68%).
Performance
FUSN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
-$70.37 M
-$65.13 M-1242.45%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly cash flow from investing activities is -$70.37 million, with the most recent change of -$65.13 million (-1242.45%) on March 31, 2024.
- Over the past year, FUSN quarterly CFI has dropped by -$83.70 million (-628.07%).
Performance
FUSN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
-$88.61 M
-$45.84 M-107.20%
March 31, 2024
Summary
- As of February 10, 2025, FUSN TTM cash flow from investing activities is -$88.61 million, with the most recent change of -$45.84 million (-107.20%) on March 31, 2024.
- Over the past year, FUSN TTM CFI has dropped by -$8.15 million (-10.13%).
Performance
FUSN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
FUSN Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -285.2% | -628.1% | -10.1% |
3 y3 years | +79.7% | -628.1% | -10.1% |
5 y5 years | -3707.9% | -628.1% | -10.1% |
FUSN Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -213.2% | at low | -288.9% | at low | -191.4% | at low |
5 y | 5-year | -213.2% | +392.1% | -288.9% | +120.4% | -191.4% | +170.0% |
alltime | all time | -213.2% | +392.1% | -288.9% | +120.4% | -191.4% | +170.0% |
Fusion Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | - | -$70.37 M(+1242.4%) | -$88.61 M(+107.2%) |
Dec 2023 | -$42.76 M(-285.2%) | -$5.24 M(-139.3%) | -$42.76 M(-46.8%) |
Sep 2023 | - | $13.33 M(-150.6%) | -$80.45 M(+42.3%) |
Jun 2023 | - | -$26.32 M(+7.3%) | -$56.53 M(+174.8%) |
Mar 2023 | - | -$24.53 M(-42.9%) | -$20.57 M(-189.1%) |
Dec 2022 | $23.09 M(-38.9%) | -$42.93 M(-215.3%) | $23.09 M(-76.2%) |
Sep 2022 | - | $37.25 M(+286.3%) | $96.92 M(+5.5%) |
Jun 2022 | - | $9.64 M(-49.6%) | $91.89 M(+7.0%) |
Mar 2022 | - | $19.13 M(-38.1%) | $85.90 M(+127.4%) |
Dec 2021 | $37.77 M | $30.90 M(-4.1%) | $37.77 M(-125.5%) |
Sep 2021 | - | $32.22 M(+780.5%) | -$148.23 M(-37.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $3.66 M(-112.6%) | -$235.41 M(-1.6%) |
Mar 2021 | - | -$29.00 M(-81.3%) | -$239.24 M(+13.7%) |
Dec 2020 | -$210.45 M(>+9900.0%) | -$155.10 M(+182.2%) | -$210.45 M(+279.4%) |
Sep 2020 | - | -$54.97 M(>+9900.0%) | -$55.47 M(+7973.5%) |
Jun 2020 | - | -$168.00 K(-21.5%) | -$687.00 K(+8.9%) |
Mar 2020 | - | -$214.00 K(+84.5%) | -$631.00 K(+38.4%) |
Dec 2019 | -$456.00 K(-59.4%) | -$116.00 K(-38.6%) | -$456.00 K(+34.1%) |
Sep 2019 | - | -$189.00 K(+68.8%) | -$340.00 K(+125.2%) |
Jun 2019 | - | -$112.00 K(+187.2%) | -$151.00 K(+287.2%) |
Mar 2019 | - | -$39.00 K | -$39.00 K |
Dec 2018 | -$1.12 M(+1069.8%) | - | - |
Dec 2017 | -$96.00 K | - | - |
FAQ
- What is Fusion Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual CFI year-on-year change?
- What is Fusion Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly CFI year-on-year change?
- What is Fusion Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals TTM CFI year-on-year change?
What is Fusion Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of FUSN is -$42.76 M
What is the all time high annual CFI for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual cash flow from investing activities is $37.77 M
What is Fusion Pharmaceuticals annual CFI year-on-year change?
Over the past year, FUSN annual cash flow from investing activities has changed by -$65.85 M (-285.23%)
What is Fusion Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of FUSN is -$70.37 M
What is the all time high quarterly CFI for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly cash flow from investing activities is $37.25 M
What is Fusion Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, FUSN quarterly cash flow from investing activities has changed by -$83.70 M (-628.07%)
What is Fusion Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of FUSN is -$88.61 M
What is the all time high TTM CFI for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM cash flow from investing activities is $96.92 M
What is Fusion Pharmaceuticals TTM CFI year-on-year change?
Over the past year, FUSN TTM cash flow from investing activities has changed by -$8.15 M (-10.13%)